Empowering women : The importance of choice in HIV prevention methods
A message from Burnet Director and CEO, Professor Brendan Crabb AC, ahead of World AIDS Day
Low- and middle-income countries face high levels of antimicrobial resistance amid global awareness week
A year after Pakistan’s floods, 44 percent of children have stunted growth. What can be done about it?
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Effectiveness of community-based oral antiviral treatments against severe COVID-...
Sequence elements within the PEXEL motif and its downstream region modulate PTEX...
Contemporary pathways to adolescent pregnancy in Indonesia: A qualitative invest...
Determining reinfection rates by hepatitis C testing interval among key populati...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Current Appeal
Donating for Individuals
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Burnet is committed to strengthening health systems in collaboration with Government and non-Governm...
Burnet’s epidemiological studies help inform policy and practice, and provide evidence-based recomme...
Burnet is at the forefront of using data and modelling across areas including COVID-19, hepatitis C ...
We perform discovery research in the areas of life sciences, biomedicine, qualitative and quantitati...
Burnet works in partnership with people and affected communities to bring about sustainable change. ...
Burnet Institute develops, tests, and evaluates new tools, interventions, and programs to address pu...